- Home
- SLS vs TWN Comparison
SLS vs TWN Comparison
Compare SLS & TWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- TWN
- Stock Information
- Founded
- SLS 2012
- TWN 1986
- Country
- SLS United States
- TWN Hong Kong
- Employees
- SLS N/A
- TWN N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- TWN Trusts Except Educational Religious and Charitable
- Sector
- SLS Health Care
- TWN Finance
- Exchange
- SLS Nasdaq
- TWN Nasdaq
- Market Cap
- SLS 169.6M
- TWN 193.5M
- IPO Year
- SLS N/A
- TWN N/A
- Fundamental
- Price
- SLS $1.71
- TWN $37.77
- Analyst Decision
- SLS
- TWN
- Analyst Count
- SLS 0
- TWN 0
- Target Price
- SLS N/A
- TWN N/A
- AVG Volume (30 Days)
- SLS 2.9M
- TWN 20.1K
- Earning Date
- SLS 05-13-2025
- TWN 01-01-0001
- Dividend Yield
- SLS N/A
- TWN 1.10%
- EPS Growth
- SLS N/A
- TWN N/A
- EPS
- SLS N/A
- TWN N/A
- Revenue
- SLS N/A
- TWN N/A
- Revenue This Year
- SLS N/A
- TWN N/A
- Revenue Next Year
- SLS N/A
- TWN N/A
- P/E Ratio
- SLS N/A
- TWN N/A
- Revenue Growth
- SLS N/A
- TWN N/A
- 52 Week Low
- SLS $0.77
- TWN $25.22
- 52 Week High
- SLS $2.12
- TWN $41.51
- Technical
- Relative Strength Index (RSI)
- SLS 54.26
- TWN 72.66
- Support Level
- SLS $1.36
- TWN $36.61
- Resistance Level
- SLS $2.12
- TWN $37.47
- Average True Range (ATR)
- SLS 0.18
- TWN 0.76
- MACD
- SLS -0.01
- TWN 0.05
- Stochastic Oscillator
- SLS 46.05
- TWN 91.10
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About TWN Taiwan Fund Inc. (The)
Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.